✦ LIBER ✦

Limitations of Using Outcomes in the Placebo Arm of a Clinical Trial of Benign Prostatic Hyperplasia to Quantify Those in the Community

✍ Scribed by Roberts, Rosebud O.; Lieber, Michael M.; Jacobson, Debra J.; Girman, Cynthia J.; Jacobsen, Steven J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Terazosin in the Treatment of Benign Pro

✍ S. N. LLOYD; J. F. BUCKLEY; C. P. CHILTON; I. IBRAHIM; A. V. KAISARY; D. KIRK 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

Randomised, placebo-controlled, double-b

✍ R.R. Berges; J. Windeler; H.J. Trampisch; Th Senge; β-sitosterol study group 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 465 KB

Resistance index in benign prostatic hyp

✍ NOBUO TSURU; YUTAKA KURITA; KAZUO SUZUKI; KIMIO FUJITA 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Transrectal Ultrasonography to Predict t

✍ Yutaka Kurita; Tomomi Ushiyama; Kazuo Suzuki; Kimio Fujita; Kazuki Kawabe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

A 12-Week Placebo-controlled Double-blin

✍ C. R. CHAPPLE; M. STOTT; P. H. ABRAMS; T. J. CHRISTMAS; E. J. G. MILROY 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

A 12-Week Placebo-controlled Double-blin

✍ C. R. CHAPPLE; M. STOTT; P. H. ABRAMS; T. J. CHRISTMAS; E. J. G. MILROY 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 805 KB